NCT03497429View on ClinicalTrials.gov

A Study of Niraparib as Single Agent in Participants With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 5, 2018

Primary Completion Date

February 10, 2020

Study Completion Date

February 10, 2020

Conditions
Advanced Solid Tumors
Interventions
DRUG

Niraparib

Niraparib capsule

Trial Locations (1)

Unknown

National Cancer Center Hospital, Chuo-ku

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT03497429 - A Study of Niraparib as Single Agent in Participants With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter